Profile for China Patent: 101132820
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for China Patent: 101132820
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jan 24, 2026 | Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate |
| ⤷ Start Trial | Jan 24, 2026 | Assertio Speclty | OTREXUP | methotrexate |
| ⤷ Start Trial | Jan 24, 2026 | Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate |
| ⤷ Start Trial | Oct 4, 2026 | Assertio Speclty | OTREXUP | methotrexate |
| ⤷ Start Trial | Oct 4, 2026 | Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate |
| ⤷ Start Trial | Jan 24, 2026 | Assertio Speclty | OTREXUP | methotrexate |
| ⤷ Start Trial | Jan 24, 2026 | Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
